FDA Clears Oral Fluid and Hair Drug Tests for DOT Use

The Food and Drug Administration cleared oral fluid and hair follicle drug tests for use in Department of Transportation testing programs on October 8, 2026. The Federal Motor Carrier Safety Administration can now accept these specimen types alongside urine for federally mandated pre-employment, random, post-accident, reasonable suspicion, return-to-duty, and follow-up testing.

When can carriers start using oral fluid or hair tests for DOT drug screens?

Carriers can use FDA-cleared oral fluid and hair tests immediately for DOT-mandated drug screening. The FMCSA Drug and Alcohol Clearinghouse accepts results from any specimen type the FDA has approved. Carriers must still use laboratories certified by the Department of Health and Human Services and follow collection procedures in 49 CFR Part 40 once the agency updates those procedures to cover the new specimen types.

The American Trucking Associations spent years pressing the FDA to approve alternative testing methods. ATA called the October 8 clearance an important step toward strengthening highway safety. The trade group argued that oral fluid and hair testing close detection windows urine tests miss and make cheating harder.

What oral fluid and hair tests detect that urine misses

Oral fluid tests detect recent drug use within the past 24 to 48 hours. Hair follicle tests detect use over the previous 90 days. Urine tests typically capture use within the past three to five days for most substances. The longer detection window for hair and the immediate-use window for oral fluid give carriers visibility into driver behavior urine cannot provide.

Hair tests are harder to adulterate than urine. A donor cannot dilute, substitute, or spike a hair sample during collection the way they can with urine in an unsupervised setting. Oral fluid collection happens under direct observation, which also reduces tampering risk.

How this changes pre-employment and random testing

Carriers that struggled to fill driver seats because applicants failed urine tests for marijuana use weeks before applying may see fewer false positives with oral fluid testing. A driver who used marijuana on a Saturday night will test positive on a urine screen the following Thursday but may test negative on an oral fluid screen if 48 hours have passed. Hair testing moves the detection window in the opposite direction, flagging habitual use a urine test would miss if the driver abstained for a week before the test.

Random testing programs gain a compliance tool. A driver who knows the fleet uses hair testing understands that a single use 60 days ago will appear in the next random pull. That changes the risk calculation compared to a urine-only program where a driver can time abstinence around known testing windows.

What stays the same under 49 CFR Part 40

The FMCSA still prohibits all marijuana use by commercial drivers holding a CDL, regardless of state legalization. A positive test for THC on any specimen type triggers the same return-to-duty process: evaluation by a substance abuse professional, completion of a treatment or education program, a negative return-to-duty test, and enrollment in a follow-up testing plan. The Clearinghouse still records the violation. CSA scores still take the hit.

Carriers still cannot use at-home test kits, instant tests, or non-DOT collection procedures for federally mandated screens. Every test must go through an HHS-certified lab and follow Part 40 collection protocols. The FDA clearance does not change the five-drug panel (marijuana, cocaine, amphetamines, opioids, PCP) or the testing triggers (pre-employment, random, post-accident, reasonable suspicion, return-to-duty, follow-up).

What carriers need to update in their drug testing policies

Carriers that want to use oral fluid or hair testing must update their drug and alcohol testing policy to specify which specimen types the company will use and under what circumstances. The policy must still comply with 49 CFR Part 40. Carriers must notify drivers of any policy change before implementing it.

Carriers must contract with collection sites and laboratories that handle the new specimen types and hold current HHS certification. Not every collection site that does urine testing has added oral fluid or hair capability. Carriers should verify lab certification and turnaround times before switching specimen types mid-program.

Cost and logistics of switching specimen types

Hair follicle tests typically cost $75 to $125 per test, compared to $40 to $60 for urine. Oral fluid tests run $50 to $80. Carriers with tight margins may keep urine for random testing and reserve hair or oral fluid for pre-employment screens where the longer or shorter detection window justifies the cost.

Collection is faster. Oral fluid collection takes two to three minutes with no privacy concerns. Hair collection takes under five minutes. Urine collection requires a private restroom, a waiting period if the donor cannot produce a sample immediately, and temperature checks to detect substitution. Carriers that operate out of terminals without on-site collection facilities may find oral fluid or hair testing easier to schedule.

What this means for Clearinghouse queries and SAP referrals

The Clearinghouse does not distinguish between specimen types. A positive test is a positive test. Pre-employment queries will return the same violation record whether the driver failed a urine, oral fluid, or hair test. Carriers hiring a driver with a Clearinghouse violation must still verify the driver completed the return-to-duty process with a substance abuse professional before putting them behind the wheel.

Substance abuse professionals evaluate drivers based on the violation, not the specimen type. A driver who tested positive for cocaine on a hair test follows the same SAP process as a driver who tested positive on a urine test. The SAP determines the treatment plan. The carrier pays for the follow-up testing, which can use any FDA-cleared specimen type the carrier's policy allows.

The compliance step carriers must take this week

Carriers that want to use oral fluid or hair testing should contact their third-party administrator or medical review officer to confirm the lab holds current HHS certification for the specimen types the carrier plans to use. Verify the lab's turnaround time and cost per test. Update the company's written drug and alcohol testing policy to specify which specimen types will be used for which testing categories (pre-employment, random, post-accident, reasonable suspicion, return-to-duty, follow-up). Notify all drivers of the policy change in writing before the first test under the new policy. Carriers that skip the written notice risk a Part 40 procedural violation during an audit.